Serotonergic neurotransmission has been implicated in memory impairment. It is uncLear however if memory performance is mediated through general 5-HT availability, through specific 5-HT receptors or both. The aim of the present study was to assess the contribution of 5-HT reuptake inhibition and specific blockade of 5-HT1A and 5-HT2A receptors to memory impairment.
The study was conducted according to a randomized, double-blind, placebo-controlled, four-way cross-over design including 16 healthy volunteers. The treatment consisted of oral administration of escitalopram 20 mg + placebo, escitalopram 20 mg + ketanserin 50 mg, escitalopram 20 mg + pindolol 10 mg and placebo on 4 separate days with a washout period of minimum 7 days. Different memory tasks were performed including verbal memory, spatial working memory and reversal learning.
Escitalopram showed an impairing effect on immediate verbal recall which nearly reached statistical significance. No effects of escitalopram were found on other types of memory. In combination with pindolol, immediate verbal recall was significantly impaired. Escitalopram in combination with ketanserin impaired spatial working memory significantly. No effects were found on reversal learning.
Selective impairment of immediate verbal recall after a 5-HT1A partial agonist and selective impairment of spatial working memory performance after 5-HT2A receptor antagonist, both in combination with a selective serotonergic reuptake inhibitor (escitalopram), suggests that 5-HT1A and 5-HT2A receptors are distinctly involved in verbal and spatial memory.
Aellig W.H. , Narjes H.H. , Nuesch E. , Oertle R.J. , Devos J.E. , Pacha W. (1981) A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet . Eur J Clin Pharmacol20: 179—183
2.
Anderson G.M. , Barr C.S. , Lindell S. , Durham A.C. , Shifrovich I. , Higley J.D. (2005) Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey . Psychopharmacology178: 339—346
3.
Aronson S. , Delgado P. (2004) Escitalopram . Drugs Today (Barc)40: 121—131
4.
Blier P. , Pineyro G. , el Mansari M. , Bergeron R. , de Montigny C. (1998) Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission . Ann N Y Acad Sci861: 204—216
5.
Bortolozzi A. , Diaz Mataix L , Scorza M.C. , Celada P. , Artigas F. (2005) The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity . J Neurochem95: 1597—1607
6.
Buhot M.C. , Martin S. , Segu L. ( 2000) Role of serotonin in memory impairment . Ann Med32: 210—221
7.
Cools R. , Clark L. , Owen A.M. , Robbins T.W. (2002) Defining the neural mechanisms of probalistic reversal learning using event-related functional magnetic resonance imaging . J Neurosci22: 4563—4567
8.
Curran H.V. , Travill R.A. (1997) Mood and cognitive effects of +/—3,4-methylenedioxymethamphetamine (MDMA, `ecstasy'): week-end `high' followed by mid-week low . Addiction Abingdon, England92: 821—831
9.
de Quervain D.J. , Henke K. , Aerni A. , Coluccia D. , Wollmer M.A. , Hock C. , Nitsch R.M. , Papassotiropoulos A. (2003) A functional genetic variation of the 5-HT2A receptor affects human memory . Nat Neurosci6: 1141—1142
10.
Di Matteo V , De Blasi A , Di Giulio C , Esposito E. (2001) Role of 5-HT(2C) receptors in the control of central dopamine function . Trends Pharmacol Sci22: 229—232
11.
Dwivedi Y. , Pandey G.N. (1998) Quantitation of 5-HT2A receptor mRNA in human postmortem brain using competitive RT-PCR . Neuroreport9: 3761—3765
12.
Ellis K.A. , Mehta M.A. , Wesnes K.A. , Armstrong S. , Nathan P.J. (2005) Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans . Psychopharmacology181: 771—780
13.
Esposito E. (2006) Serotonin—dopamin interaction as a focus of novel antidepressant drugs. Current DrugTargets7: 177—185
14.
Evers E A T , Cools R. , Clark L. , van der Veen F.M. , Jolles J. , Sahakian B.J. , Robbins T.W. (2005a) Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning . Neuropsychopharmacology : 1—10
15.
Evers E.A. , Tillie D.E. , van der Veen F.M. , Lieben C.K. , Jolles J. , Deutz N.E. , Schmitt J.A. (2005b) Effects of a novel method of acute tryptophan depletion on plasma tryptophan and cognitive performance in healthy volunteers . Psychopharmacology178: 92—99
16.
Gallagher P. , Massey A.E. , Young A.H. , McAllister-Williams R.H. (2003) Effects of acute tryptophan depletion on executive function in healthy male volunteers . BMC-Psychiatry3: 10
17.
Harmer C.J. , Bhagwagar Z. , Cowen P.J. , Goodwin G.M. (2002) Acute administration of citalopram facilitates memory consolidation in healthy volunteers . Psychopharmacology163: 106—110
18.
Harmer C.J. , McTavish S F B , Clark L. , Goodwin G.M. , Cowen P.J. (2001) Tyrosine depletion attenuates dopamine function in healthy volunteers . Psychopharmacology154: 105—111
19.
Harrison B.J. , Olver J.S. , Norman T.R. , Burrows G.D. , Wesnes K.A. , Nathan P.J. (2004) Selective effects of acute serotonin and catecholamine depletion on memory in healthy women . J Psychopharmacol18: 32—40
20.
Hedner T. , Persson B. , Berglund G. (1983) Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension . Br J Clin Pharmacol16: 121—125
21.
Hughes J.H. , Gallagher P. , Stewart M.E. , Matthews D. , Kelly T.P. , Young A.H. (2003) The effects of acute tryptophan depletion on neuropsychological function . J Psychopharmacol17: 300—309
22.
Kuypers K P C , Ramaekers J.G. (2005) Transient memory impairment after acute dose of 75 mg 3.4-methylene-dioxymethamphetamine . J Psychopharmacol19: 633—639
23.
Kuypers K P C , Ramaekers J.G. (2006) Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected . Psychopharmacology. Neuropsychopharmacology: 1—8
24.
Liechti M.E. , Saur M.R. , Gamma A. , Hell D. , Vollenweider F.X. (2000) Psychological and physiological effects of MDMA (`Ecstasy') after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans . Neuropsychopharmacology23: 396—404
25.
Lucas G. , Spampinato U. (2000) Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum . J Neurochem74: 693—701
26.
Luciana M. , Collins P.F. , Depue R.A. (1998) Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions . Cereb Cortex8: 218—226
27.
McNair D.M. , Lorr M. , Droppleman L.F. (1992) Manual for the Profile of Mood States (Revised) . Educational and Industrial Testing Service, San Diego
28.
Meeter M. , Talamini L. , Schmitt J.A. , Riedel W.J. (2006) Effects of 5-HT on memory and the hippocampus: model and data . Neuropsychopharmacology31: 712—720
29.
Meneses A. (2002) Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?Cell Mol Neurobiol22: 675—688
30.
Murphy F.C. , Smith K.A. , Cowen P.J. , Robbins T.W. , Sahakian B.J. (2002) The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers . Psychopharmacology163: 42—53
31.
Parrott A.C. , Lees A. , Garnham N.J. , Jones M. , Wesnes K. (1998) Cognitive performance in recreational users of MDMA of `ecstasy': evidence for memory deficits . J Psychopharmacol12: 79—83
32.
Rabiner E.A. , Bhagwagar Z. , Gunn R.N. , Cowen P.J. , Grasby P.M. (2004) Preferential 5-HT1A autoreceptor occupancy by pindolol is attenuated in depressed patients: effect of treatment or an endophenotype of depression ? Neuropsychopharmacology29: 1688—1698
33.
Rabiner E.A. , Bhagwagar Z. , Gunn R.N. , Sargent P.A. , Bench C.J. , Cowen P.J. , Grasby P.M. (2001) Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low . Am J Psychiatry158: 2080—2082
34.
Rabiner E.A. , Gunn R.N. , Wilkins M.R. , Sargent P.A. , Mocaer E. , Sedman E. , Cowen P.J. , Grasby P.M. (2000) Drug action at the 5-HT(1A) receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11C]WAY-100635 . Nucl Med Biol27: 509—513
35.
Rasmussen K. , McCreary A.C. , Shanks E.A. (2004) Attenuation of the effects of fluoxetine on serotonergic neuronal activity by pindolol in rats . Neurosci Lett355: 1—4
36.
Rey A. ( 1964) L'examen psychologique dans les cas d'encéphalopathie traumatique. Presses Universitaires de France, Paris
37.
Riedel W.J. , Eikmans K. , Heldens A. , Schmitt J.A. (2005) Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment . J Psychopharmacol19: 12—20
38.
Riedel W.J. , Klaassen T. , Deutz N.E. , van Someren A. , van Praag H.M. (1999) Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation . Psychopharmacology.141: 362—9
39.
Riedel W.J. , Klaassen T. , Griez E. , Honig A. , Menheere P.P. , van Praag H.M. (2002) Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood . Neuropsychopharmacology26: 358—367
40.
Robbins T.W. (2000) Chemical neuromodulation of frontal-executive functions in humans and other animals . Exp Brain Res133: 130—138
41.
Schmitt J.A. , Jorissen B.L. , Sobczak S. , van Boxtel M.P. , Hogervorst E. , Deutz N.E. , Riedel W.J. (2000) Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers . J Psychopharmacol14: 21—29
42.
Schmitt J A J , Wingen M. , Ramaekers J.G. , Evers E A T , Riedel W.J. (2006) Serotonin and human cognitive performance . Curr Pharm Des12: 2473—2486
43.
Vermeeren A. , Jackson J.L. , Muntjewerff N.D. , Quint P.J. , Harrison E.M. , O'Hanlon J.F. (1995) Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests . Psychopharmacology118: 1—9
44.
Vollenweider F.X. , Vollenweider Scherpenhuyzen M.F. , Babler A. , Vogel H. , Hell D. (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action . Neuroreport9: 3897—3902
45.
Wilkinson C.J. , Lee G.S. , Chang C. , Ventura D. (2003) The effects of escitalopram administered alone and with alcohol on cognition and psychomotor performance . NIMH-43rd Annual NCDEU Meeting: poster session I
46.
Wingen M. , Langer S. , Ramaekers J.G. (2006) Verbal memory performance during subchronic challenge with a selective serotonergic and a mixed action antidepressant . Human Psychopharmacology, DOI: 10.1002/ hup.800
47.
Yasuno F. , Suhara T. , Nakayama T. , Ichimiya T. , Okubo Y. , Takano A. , Ando T. , Inoue M. , Maeda J. , Suzuki K. (2003) Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory . Am J Psychiatry160: 334—340
